# Distinguishing Physiological Ureter Uptake From an Involved Lymph Node in Staging Prostate-Specific Membrane Antigen (PSMA) Scans: Implications for Radiation Planning

**Authors:** Lauren Ching, Matthew Bourne, Tim Kearney, Karbi Choudhury, Alan L Zwart, Malika T Danner, Simeng Suy, Giuseppe Esposito, Sean Collins

PMC · DOI: 10.7759/cureus.63105 · 2024-06-25

## TL;DR

This paper discusses how PSMA scans can mistakenly identify normal ureter activity as cancerous lymph nodes, which can lead to unnecessary radiation treatment in prostate cancer patients.

## Contribution

The paper highlights the diagnostic challenge of distinguishing physiological ureter uptake from malignant lymph nodes in PSMA imaging for prostate cancer.

## Key findings

- PSMA scans can misinterpret normal ureter activity as lymph node metastases.
- Accurate interpretation of PSMA uptake patterns is crucial to avoid unnecessary radiation.
- A second imaging modality like CT urogram can clarify ambiguous PSMA findings.

## Abstract

Prostate-specific membrane antigen (PSMA) imaging has become a mainstay diagnostic tool in staging unfavorable primary prostate cancer (PC) and identifying sites of recurrence in previously treated PC. One of the biggest pitfalls of PSMA imaging is rapid radionucleotide excretion in the urine via the​ kidneys, ureters, and bladder.​ The positron-emission tomography (PET) images obtained show increased radiotracer activity in these structures, which can occlude or even mimic true malignant disease. We describe the diagnostic challenges encountered in differentiating benign versus malignant disease with PSMA scans. A 78-year-old male presented ​to our outpatient radiation oncology office ​with high-risk prostate cancer. His medical history was significant for ulcerative colitis (UC). Magnetic resonance imaging (MRI) revealed an enlarged prostate and a Prostate Imaging Reporting and Data System (PI-RADS) class 4 lesion. A subsequent transperineal biopsy confirmed unilateral Gleason 8 adenocarcinoma.

A PSMA PET scan was read as increased uptake in the right prostate and a left external iliac node. The patient, having been initially informed of a positive lymph node metastasis, sought a second opinion,​resulting in​​ ​a CT urogram that revealed physiologic ureteral uptake. We were thus able to avoid lymph node radiation and morbidity to the surrounding bowel, already chronically inflamed with ulcerative colitis. This study ​demonstrates the ​potential for misinterpretation of PSMA uptake in the ureter as lymph node metastases. We discuss how peri-uretic activity can hinder accurate visualization of pelvic lymph node metastases. This study highlights the need for careful image interpretation of PSMA uptake patterns in order to avoid diagnostic errors and unnecessary radiation to ​at-risk​​ ​organs in prostate cancer management.

## Linked entities

- **Proteins:** FOLH1 (folate hydrolase 1)
- **Diseases:** prostate cancer (MONDO:0005159), ulcerative colitis (MONDO:0005101)

## Full-text entities

- **Genes:** FOLH1 (folate hydrolase 1) [NCBI Gene 2346] {aka FGCP, FOLH, GCP2, GCPII, NAALAD1, PSM}
- **Diseases:** Gleason 8 adenocarcinoma (MESH:D000230), UC (MESH:D003093), lymph node metastases (MESH:D008207), PC (MESH:D011471), malignant (MESH:D009369)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11271162/full.md

---
Source: https://tomesphere.com/paper/PMC11271162